We also tested the effect of infection with the PPRV vaccine strain (Nigeria/75/1) [54], using a recombinant version [55], which we also used in later experiments to introduce mutations into PPRV; we observed that this virus also failed to activate the IFN-β promoter (Fig 1D). The gene discussed is IFNB1; the disease is infection.